Key Points Electric vehicle maker reported stronger-than-expected growth in its deliveries in Q2. The share price drop underscores investors’ difficulty in pricing shares of an EV company that’s also evolving into an AI outfit. Shareholders must recognize that Tesla ebbs and flows differently, forcing investors to own it with one of two very specific mindsets. … Read more

QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway

The whipping post

uniQure N.V. QURE remains a catalyst-driven gene therapy stock, with AMT-130 shaping most of the investment debate. The program targets Huntington’s disease, an area where disease-modifying options remain absent. Recent FDA feedback, a targeted biologics license application submission in the third quarter of 2026 and a cash runway into the second half of 2029 now … Read more

Why Apple Stock Climbed to a New All-Time High Today

The whipping post

Key Points Innovative new tech could bring the power of advanced AI models to the iPhone. Partnerships with Chinese cloud leaders will help Apple bring AI services to its largest international market. 10 stocks we like better than Apple › Shares of Apple (NASDAQ: AAPL) jumped to a record high on Wednesday, following some positive … Read more